Ruhrpharm AG
Medical Technology · Bielefeld
Ruhrpharm AG is a medical technology company based in Bielefeld, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Ruhrpharm AG Address & Contact
Website
Ruhrpharm AG Overview
Ruhrpharm AG is an established pharmaceutical company and wholesale distributor of medicinal products based in Bielefeld, North Rhine-Westphalia. With many years of experience in the industry, the company stands out due to its excellent networking with pharmacies, clinics, and other medical facilities in the East Westphalia-Lippe region. Ruhrpharm AG has made a name for itself through its reliability and innovation and is an important partner in the healthcare sector of the region and beyond.
Services and Products
Ruhrpharm AG offers a comprehensive range of pharmaceutical products and medicines specifically designed for various medical needs. The main product areas include:
- Medicines: A wide selection of prescription and over-the-counter medications tailored to the needs of pharmacies and clinics.
- Medical Devices: High-quality medical devices that meet the latest medical standards and are used in patient care.
- Pharmaceutical Services: In addition to distribution, the company provides various services in the area of medicinal logistics, ensuring safe and efficient storage and transport of medications.
- Cold Storage: Specialized in the storage and distribution of temperature-sensitive pharmaceutical products, Ruhrpharm guarantees compliance with cold chains, which is of particular significance in modern medicine.
Ruhrpharm AG places great importance on the quality of its products and their origin. For manufacturing and distribution, the company collaborates with well-known manufacturers and is subject to strict regulatory requirements that ensure all products comply with applicable safety standards.
Regulatory Classification and Quality Assurance
Ruhrpharm AG is licensed as a pharmaceutical wholesaler according to the provisions of the Medicines Act (AMG) and the guidelines of the German Pharmacopoeia (DAB). This regulatory classification requires regular inspections and audits to maintain high standards in quality assurance. Compliance with Good Distribution Practice (GDP) is central to the company's operations and ensures that all medicines and medical devices arrive in perfect condition.
Location Bielefeld / North Rhine-Westphalia
Bielefeld is the heart of the East Westphalia-Lippe economic region and plays a central role in healthcare. The city is home to significant institutions such as the Evangelisches Klinikum Bethel (EvKB) and Klinikum Bielefeld, which act as major healthcare providers in the region. This proximity to such important institutions not only enables Ruhrpharm AG to collaborate closely but also provides direct access to innovative treatment methods and medical standards.
Furthermore, companies involved in pharmaceutical logistics in Bielefeld benefit from excellent infrastructure. The connections to the A2 and A33 motorways, as well as proximity to Münster/Osnabrück Airport, allow for efficient distribution throughout the entire Rhine-Ruhr metropolitan region and beyond. This creates logistical advantages and accelerates delivery times for customers in the region.
Special Features and Innovation Approach
A unique selling point of Ruhrpharm AG is its strong focus on innovation and continuous adaptation to the rapidly changing needs of the healthcare market. The company continuously invests in modern technologies to optimize processes and enhance customer satisfaction. These include digital solutions for order acceptance and processing as well as the implementation of seamless traceability in the supply chain.
Ruhrpharm AG is also committed to sustainable practices in the pharmaceutical industry. This includes using environmentally friendly packaging materials and minimizing the ecological footprint through environmentally conscious logistics processes. The company's philosophy is not only to provide the best service but also to take responsibility for the environment and society.
Other medical technology companies: Medical Technology Overview | Medical Technology NRW | Pharmaceutical Companies | Pharmaceutical Wholesaling
```Frequently asked questions about Ruhrpharm AG
What does Ruhrpharm AG do?
Ruhrpharm AG is a company in the medical technology sector based in Bielefeld. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is Ruhrpharm AG located?
Ruhrpharm AG is headquartered in Bielefeld. More information can be found on the company's website.
In which area of medical technology is Ruhrpharm AG active?
Ruhrpharm AG is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
Ruhrpharm AG on social media
More Medical Technology in Bielefeld
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.